Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Quarterly Revenue, Financial Performance, and Segment Results
ZBH logo

Zimmer Biomet Sales Surge 9.3% to $2.08 Billion Amid Strategic Acquisitions

ZBH10-QFiling Date: 5/1/2026
Zimmer Biomet Holdings, Inc.
Description

What this story covers

Zimmer Biomet reports a 9.3% revenue increase driven by the Paragon 28 acquisition and strong hip and knee sales. The company is navigating $7.47 billion in debt and distributor disputes in China while executing a major restructuring plan.

Story snapshot

CompanyZimmer Biomet Holdings, Inc.
TickerZBH
VariantStandard detailed
Duration13:50
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001193125-26-201710
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in